|
|
||||||||
The Journal of Immunology, Vol 158, Issue 9 4097-4103, Copyright © 1997 by American Association of Immunologists
ARTICLES |
V Giordano, G De Falco, R Chiari, I Quinto, PG Pelicci, L Bartholomew, P Delmastro, M Gadina and G Scala
Department of Biochemistry and Biomedical Technology, Medical School, University Federico II, Naples, Italy.
IL-6 is a multifunctional cytokine involved in hemopoiesis, immune regulation, inflammation, neural development, and infection. IL-6 belongs to a family of related cytokines that includes leukemia inhibitory factor, oncostatin M, IL-11, ciliary neurotropic factor, and cardiotropin-1, all of which initiate signaling through a receptor- associated gp130. IL-6 induces homodimerization of gp130 and activates the Jak/STAT pathway of signal transduction. In addition, IL-6 stimulates the mitogen-activated protein kinases designated ERK (extracellular signal-regulated kinase)-1 and -2. Activation of ERK-1 and -2 may involve the Src homology-2 containing proteins Shc and Grb2. Here we provide evidence that Shc could function as signaling molecules for IL-6 in DeFew-IL-6R/gp130 cells, a human B lymphoma cell line engineered to express high levels of both the IL-6R (p80) and the gp130 subunit. IL-6 was shown to promote the rapid tyrosine phosphorylation of gp130, Jak2, and Shc proteins. Moreover, Shc associated both in vivo and in vitro with phosphorylated gp130 through the Shc-Src homology-2 domain. We also report that Shc bound to activated Jak2 by using the Shc amino terminal phosphotyrosine interaction domain. Following IL-6 stimulation, Shc physically associated with Grb2. Thus, the data point to Shc proteins as a functional link between the Jak2 and Ras pathways of IL-6 signal transduction.
This article has been cited by other articles:
![]() |
Y. Tanaka, N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii, and K. Sugamura c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130 Mol. Cell. Biol., August 1, 2008; 28(15): 4805 - 4818. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Pathak, M. Bhutani, A. S. Nair, K. S. Ahn, A. Chakraborty, H. Kadara, S. Guha, G. Sethi, and B. B. Aggarwal Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells Mol. Cancer Res., September 1, 2007; 5(9): 943 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Borowiak, A. N. Garratt, T. Wustefeld, M. Strehle, C. Trautwein, and C. Birchmeier Met provides essential signals for liver regeneration PNAS, July 20, 2004; 101(29): 10608 - 10613. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Chang, M. J. Holtzman, and C.-C. Chen Differential Role of Janus Family Kinases (JAKs) in Interferon-{gamma}-Induced Lung Epithelial ICAM-1 Expression: Involving Protein Interactions between JAKs, Phospholipase C{gamma}, c-Src, and STAT1 Mol. Pharmacol., March 1, 2004; 65(3): 589 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Stankoff, M.-S. Aigrot, F. Noel, A. Wattilliaux, B. Zalc, and C. Lubetzki Ciliary Neurotrophic Factor (CNTF) Enhances Myelin Formation: A Novel Role for CNTF and CNTF-Related Molecules J. Neurosci., November 1, 2002; 22(21): 9221 - 9227. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Wu and R. A. Bradshaw Activation of the Stat3 Signaling Pathway Is Required for Differentiation by Interleukin-6 in PC12-E2 Cells J. Biol. Chem., January 21, 2000; 275(3): 2147 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Paradis and R. Gendron LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase J. Cell Sci., January 12, 2000; 113(23): 4331 - 4339. [Abstract] [PDF] |
||||
![]() |
S. Rivest, S. Lacroix, L. Vallières, S. Nadeau, J. Zhang, and N. Laflamme How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli Experimental Biology and Medicine, January 1, 2000; 223(1): 22 - 38. [Abstract] [Full Text] |
||||
![]() |
M. Ernst, U. Novak, S. E. Nicholson, J. E. Layton, and A. R. Dunn The Carboxyl-terminal Domains of gp130-related Cytokine Receptors Are Necessary for Suppressing Embryonic Stem Cell Differentiation. INVOLVEMENT OF STAT3 J. Biol. Chem., April 2, 1999; 274(14): 9729 - 9737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Lange, J. K. Richer, T. Shen, and K. B. Horwitz Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer. POTENTIATION OF MITOGEN-ACTIVATED PROTEIN KINASE PATHWAYS J. Biol. Chem., November 20, 1998; 273(47): 31308 - 31316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, T. S. Hawley, R. G. Hawley, and H. Baumann Protein Tyrosine Phosphatase 2 (SHP-2) Moderates Signaling by gp130 but Is Not Required for the Induction of Acute-Phase Plasma Protein Genes in Hepatic Cells Mol. Cell. Biol., March 1, 1998; 18(3): 1525 - 1533. [Abstract] [Full Text] |
||||
![]() |
Y. Wang, O. Robledo, E. Kinzie, F. Blanchard, C. Richards, A. Miyajima, and H. Baumann Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor J. Biol. Chem., August 11, 2000; 275(33): 25273 - 25285. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Hermanns, S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR J. Biol. Chem., December 22, 2000; 275(52): 40742 - 40748. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Jones, J. Conover, and A. J. Symes Identification of a Novel gp130-responsive Site in the Vasoactive Intestinal Peptide Cytokine Response Element J. Biol. Chem., November 10, 2000; 275(46): 36013 - 36020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Pitts, S. Wang, E. A. Jones, and A. J. Symes Transforming Growth Factor-beta and Ciliary Neurotrophic Factor Synergistically Induce Vasoactive Intestinal Peptide Gene Expression through the Cooperation of Smad, STAT, and AP-1 Sites J. Biol. Chem., June 1, 2001; 276(23): 19966 - 19973. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Craig, M. Wagner, T. McCardle, A. G. Craig, and C. C. Glembotski The Cytoprotective Effects of the Glycoprotein 130 Receptor-coupled Cytokine, Cardiotrophin-1, Require Activation of NF-kappa B J. Biol. Chem., September 28, 2001; 276(40): 37621 - 37629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |